What is Travere Therapeutics, Inc.'s AOCI?

Travere Therapeutics, Inc. (TVTX) reported AOCI of -$1.06M in Q1 2026.

How has Travere Therapeutics, Inc.'s AOCI changed year-over-year?

Travere Therapeutics, Inc.'s AOCI decreased by 26.0% year-over-year, from -$843K to -$1.06M.

What is the long-term trend for Travere Therapeutics, Inc.'s AOCI?

Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s AOCI has grown at a 5.7% compound annual growth rate (CAGR), from -$902K to -$1.19M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Travere Therapeutics, Inc. TVTX AOCI

AOCI at other companies

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

BridgeBio PharmaBBIO

-$8K—

Arrowhead ResearchARWR

$742K-83.1%

PTC TherapeuticsPTCT

$8.47M+161%

Scholar RockSRRK

$690K+435%

Protagonist TherapeuticsPTGX

-$269K-416%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Enterprise value$5.07B+65.5%

P/S9.6×-1.3×

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s AOCI?: Travere Therapeutics, Inc. (TVTX) reported AOCI of -$1.06M in Q1 2026.
How has Travere Therapeutics, Inc.'s AOCI changed year-over-year?: Travere Therapeutics, Inc.'s AOCI decreased by 26.0% year-over-year, from -$843K to -$1.06M.
What is the long-term trend for Travere Therapeutics, Inc.'s AOCI?: Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s AOCI has grown at a 5.7% compound annual growth rate (CAGR), from -$902K to -$1.19M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.